Skip to main content
Clinical Trials/CTRI/2011/08/001937
CTRI/2011/08/001937
Completed
Phase 3

Comparative Evaluation of Efficacy and Safety of Losartan + Metoprolol XL Combination vs.Losartan + Ramipril Combination in Patients with Essential Hypertension Along with Type II Diabetes - NI

Ipca Laboratories Ltd0 sites158 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Essential Hypertension Along with Type II Diabetes
Sponsor
Ipca Laboratories Ltd
Enrollment
158
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 30, 2013
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • To be eligible for inclusion, each patient must fulfill each of the following criteria at baseline / randomization:
  • � Patients with study related disease condition.
  • � Patients with essential hypertension
  • � Patients diagnosed of Type II diabetes
  • � The subject must agree to fully comply with study procedures and restrictions.
  • � The subject must willingly give informed consent.

Exclusion Criteria

  • � Patients with secondary hypertension.
  • � Patients with Type I diabetes mellitus.
  • � Patients with diastolic BP \>\= 110 mm Hg
  • � Patients with significant cardiovascular disease
  • � Patients with pulmonary diseases
  • � Patients with history of coronary heart disease or any other morbid condition with poor prognosis.
  • � Patients with abnormal renal and liver function
  • � Patients with electrolyte imbalance
  • � Patients with retinopathy or history of retinopathy except non\-proliferative retinopathy.
  • � Patients with disease of blood or haematopoetic organs

Outcomes

Primary Outcomes

Not specified

Similar Trials